Envoke

Envoke raises £1M Series A to enhance lab simulation training for healthcare and research

24th May, 2025

Chris Davis

Writer

Envoke raises £1M Series A to enhance lab simulation training for healthcare and research

What does Envoke do?

Envoke develops advanced simulator software that creates virtual models of laboratory equipment. This software enables medical staff to train, troubleshoot equipment issues using AI-powered diagnosis tools, and allows manufacturers to offer remote support.

How much did they raise?

The company raised £1M in Series A funding, with Mercia Ventures through NPIF – Mercia Equity Finance leading with a £500k investment, and Finance Yorkshire’s Seedcorn Fund matching with £500k.

What are their plans for the money?

With the new capital, Envoke plans to enhance their simulation system, ramp up sales and marketing efforts, and expand its customer base ahead of future investment rounds.

What have they achieved so far?

The platform is already deployed globally in labs, including NHS facilities and leading universities, and is used by major device manufacturers such as Bio-Rad, Waters Corporation, PacBio, Grifols, and Terumo Group.

Key Contacts

Stuart Warrington
CEO

Company Links

Looking for startup leads?

Every week we source, enrich and send you leads of decision makers from recently funded startups. Sent to you every Monday.

Learn more

Newsletter

Get a daily roundup of recently funded startups.

Recently raised

The latest funding rounds from our newsroom